By Tony Inglis and Calum Woodger
A £1.85m funding boost for medical research carried out at the University of Glasgow could help diagnose infectious diseases faster.
The money, given to medical technology team SAW Dx, from the IP Group, the Scottish Investment Bank and the UK government’s biomedical catalyst fund, will help create a prototype machine with a view to being produced for use in the medical market.
Dr Julien Reboud, a biomedical researcher at the university, said: “In the current state of affairs, testing takes so long that most of the time the doctors have to make an informed guess as to what to do with the patient, do we treat or do we not treat?
“In most cases, that ends up being that we need to treat, but we are not entirely sure what we are treating for.”
The unique technology behind SAW Dx was devised and developed at the university’s engineering school.
NHS Greater Glasgow and Clyde are already benefitting from the groundbreaking research as they have been the recipients of pilot technology used to detect sexually transmitted diseases.
People who catch malaria and tuberculosis may also be in line to profit from the experimental treatment.
Below: Dr Julien Reboud spoke to our broadcast team at the university earlier today
Photo credit: Flickr Creative Commons